Research indicates that while the most severe effects of SARS-CoV-2 were observed in patients with acute COVID-19, individuals who experienced milder cases and were not hospitalized also reported symptoms of memory loss and attention deficits lasting over 18 months post-infection.
Memory loss and attention deficit are common complaints among severe COVID-19 survivors. However, these and other cognitive impairments have also been observed in patients with mild cases more than 18 months after infection, according to a study by researchers at the University of São Paulo (USP) in Brazil.
An article on the study is published in the journal BMC Psychology. The findings highlight the need for more comprehensive rehabilitation to address the enduring cognitive impacts of long COVID, the authors write.
Data collected from 302 volunteers pointed to cognitive impairment in 11.7% of mild patients, 39.2% of moderate patients, and 48.9% of severe patients.
“Although the damage done by the disease in terms of memory loss, attention deficit, and slow processing increases in proportion to its severity, the same problems affect a far from a negligible number of people – around 100 in our study – who had mild or moderate COVID,” said Antônio de Pádua Serafim, first author of the article and a professor at the Institute of Psychology (IP-USP).
The results of the study, which was funded by FAPESP, evidence the potential impact of neuroinflammation due to infection by SARS-CoV-2.
“Memory loss and attention deficit are known to be associated with post-intensive care syndrome due to intubation under deep anesthesia. Some of the data analyzed in the study, however, was from patients who didn’t require intensive care or didn’t even have sufficient symptoms to be hospitalized and nevertheless exhibited memory loss and attention deficit. The findings therefore opened our eyes to the question of neuroinflammation due to COVID-19,” Serafim said.
Memory and attention are important cognitive functions that affect people’s day-to-day lives. Reflecting this, participants in the study with poor memory and attention test scores reported difficulties with recalling words or performing routine activities, such as forgetting pots on the stove or failing to pick children up from school.
“Hierarchically speaking, attention is the primary function in all mental activity, and this explains why attention deficit has such as huge impact on people’s daily lives. High-quality attention is required to think and act in various ways at the same time. Impairment of attention in turn affects memory. In some cases, attentional activity is so dispersed that each new stimulus [or impending activity] dissolves, so that the person can’t remember what they were doing. This also affects processing activity, which involves rapid decision-making based on information,” he said.
Cognitive rehabilitation
According to Serafim, all the evidence has shown for some time that SARS-CoV-2 can affect the central nervous system as well as the lungs, kidneys, heart, and muscles, but the extent of the damage it may cause is poorly understood. “We don’t know if cognitive impairment due to COVID-19 is permanent, and we’re currently evaluating ways to intervene in this process,” he said.
In partnership with other researchers at USP, Serafim is developing programs to try to mitigate the cognitive losses caused by COVID-19. The aim is to find out whether techniques such as neurostimulation and neurofeedback can attenuate or reserve memory loss and attention deficit.
“Both are non-invasive techniques that aim to improve brain functions by means of neuromodulation, which can stimulate the connections among neurons in the brain [synapses]. We have only case studies so far. For example, in the case of a physician who was in the intensive care unit for 34 days, we conducted a neurofeedback protocol often used to study patients with attention deficit disorder, and he made a good recovery. But that was an isolated case,” he said.
“Based on the knowledge we’ve acquired so far regarding cognitive stimulation and rehabilitation techniques, I believe it may be possible to obtain an improvement in neural connectivity by means of brain training to stimulate overall cognitive ability. The severe phase of the pandemic is over, but the sequelae persist. So it’s not a closed case. Many people were infected, and many have sequelae of this kind. However, we don’t have an effective program to intervene not only in the emotional aspects but also in the cognitive difficulties resulting from COVID-19.”
Reference: “Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations” by Antonio de Pádua Serafim, Fabiana Saffi, Amanda Rafaella A. Soares, Alessandra Mara Morita, Mariana Medeiros Assed, Sandro de Toledo, Cristiana C. A. Rocca and Ricardo S. S. Durães, 26 April 2024, BMC Psychology.
DOI: 10.1186/s40359-024-01740-7
The study was funded by the São Paulo Research Foundation.
News
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the [...]
Revolutionary Nanoparticle Therapy for Prostate Cancer
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and [...]
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]